Macrophage Derived Platelet Activating Factor Implicated in the Resolution Phase of Gouty Inflammation [PDF]
Human blood derived in vitro differentiated monocytes or macrophages are a population of cells which have been investigated over the years to determine the role these cells play in the resolution phase of gout.
Darshna Yagnik
doaj +3 more sources
Molecular Docking, Drug likeness Studies and ADMET prediction of Flavonoids as Platelet-Activating Factor (PAF) Receptor Binding [PDF]
Studies and scientific research indicate that the platelet-activating factor (PAF) is a major pro-inflammatory mediator in the initiation and development of cancer.
Mohammed BOUACHRINE +6 more
doaj +2 more sources
Modulation of inflammatory platelet-activating factor (PAF) receptor by the acyl analogue of PAF [PDF]
Platelet-activating factor (PAF) is a potent inflammatory mediator that exerts its actions via the single PAF receptor (PAF-R). Cells that biosynthesize alkyl-PAF also make abundant amounts of the less potent PAF analogue acyl-PAF, which competes for PAF-
Vyala Hanumanthareddy Chaithra +11 more
doaj +2 more sources
Platelet Activating Factor Acetyl Hydrolase (PAF AH) or LpPLA2 is a key enzyme in myocardial infarction catalyzes the sn-2 acetyl group of Platelet Activating Factor (PAF) into lyso PAF and acetate as non-potent inflammatory molecules ...
Jayarani Fatimah Putri +2 more
doaj +1 more source
Platelet-Activating Factor, PAF Acetylhydrolase, and Severe Anaphylaxis [PDF]
Platelet-activating factor (PAF) is an important mediator of anaphylaxis in animals, and interventions that block PAF prevent fatal anaphylaxis. The roles of PAF and PAF acetylhydrolase, the enzyme that inactivates PAF, in anaphylaxis in humans have not been reported.We measured serum PAF levels and PAF acetylhydrolase activity in 41 patients with ...
Vadas, Peter +9 more
openaire +4 more sources
Platelet-activating factor induces ferroptosis by binding to ATF3 and inhibiting the SLC7A11/GPX4 axis to suppress the progression of endometrial carcinoma [PDF]
Background Endometrial carcinoma (EC) is an aggressive gynecological malignancy with high recurrence rates and limited treatment options. Patients with EC exhibit elevated serum levels of lyso-platelet-activating factor (lyso-PAF), a biologically ...
Feifei Pan +14 more
doaj +2 more sources
Platelet-activating factor (PAF) promotes immunosuppressive neutrophil differentiation within tumors. [PDF]
Dahal A +12 more
europepmc +3 more sources
Thermal Burn Injury Generates Bioactive Microvesicles: Evidence for a Novel Transport Mechanism for the Lipid Mediator Platelet-Activating Factor (PAF) That Involves Subcellular Particles and the PAF Receptor. [PDF]
Liu L +11 more
europepmc +3 more sources
Recent topics on platelet-activating-factor(PAF).
T, Hasegawa, S, Nakajima
openaire +4 more sources
Impact of targeting the platelet-activating factor and its receptor in cancer treatment [PDF]
The lipid mediator platelet-activating factor (PAF) and its receptor (PAFR) signaling play critical roles in a wide range of physiological and pathophysiological conditions, including cancer growth and metastasis.
Kimya Qaderi +3 more
doaj +2 more sources

